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This is a case report of the ﬁrst reported laser lead extraction of
a CardioFit vagal nerve stimulator owing to automatic implant-
able cardioverter-deﬁbrillator (AICD) pocket infection.
Case report
A 61-year-old man with a history of ischemic cardiomyop-
athy status post dual-chamber Medtronic Evera XT AICD
implanted in the left infraclavicular fossa area in 2007 was
subsequently enrolled in the Innervate HF trial in 2013 and
had a CardioFix (BioControl Medical LTD, Yehud, Isreal)
neurotransmitter implanted.
The patient developed severe Staphylococcus aureus
infection of his AICD pocket shortly after a pulse generator
change of his AICD. The decision was made to remove both
implanted devices, including leads, owing to the infection.
This is a description of the ﬁrst reported extraction of the
CardioFit neurostimulator owing to infection. Figure 1
shows the chest radiograph of the patient with both devices
in place and the infected AICD pocket site.
The CardioFit is a vagal nerve stimulator that is designed
to modulate heart rate variability in patients with systolic
heart failure. Its implantation requires dissection of the right
cervical area to expose the right vagus nerve. Then a nerve
stimulation lead is inserted with distal tip encircling the
vagus nerve. This lead is an asymmetric bipolar multi-
contact cuff that is passively ﬁxated circumferentially on the
vagus nerve. The lead is then tunneled subcutaneously down
to the right infraclavicular area, where it is screwed into the
pulse generator. A standard transvenous pacemaker lead withKEYWORDS Laser; Extraction; CardioFit; Deﬁbrillator; Extracardiac; Surgical
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pulse generator.1 In this particular case a Medtronic CapSu-
reFix Novus 4076-52 cm active-ﬁxation lead was used.
The patient was taken to the hybrid operating room. As
per our institution’s protocol for lead extraction, general
anesthesia was used with endotracheal intubation. A trans-
esophageal echo probe was inserted to evaluate for any signs
of thrombus or vegetation around the leads. There was no
evidence of baseline pericardial effusion. The patient was
prepped and draped to include the neck, anterior chest, and
abdomen out to the anterior axillary line and the bilateral
groins. Prophylactic right femoral artery and venous sheaths
were inserted in case emergent bypass was required.
The location of the neurostimulator lead cuff was con-
ﬁrmed using ﬂuoroscopy. An oblique 3 cm incision was made
using the previous incision on the anterior border of the
sternocleidomastoid muscle in the lower third of the neck.
Dissection was performed with electrocautery through the
platysma muscle to the level of the carotid sheath. The
sternocleidomastoid muscle was retracted laterally. The vagus
nerve and vagal nerve stimulator cuff were identiﬁed anterior
to the internal jugular vein. The cuff was freed from the
surrounding adhesions and the vagus nerve was exposed with
sharp dissection. The locking mechanism on the stimulating
lead cuff was undone and the lead was easily removed from
the nerve (Figure 2). Careful inspection of the vagus nerve
revealed no visible damage. The pulse generator of the vagal
nerve stimulator was then exposed in the deltopectoral region
and removed from the pocket. The stimulating lead was easily
retracted into the pocket with gentle traction. A stiff stylet was
inserted in the inner core of the right ventricular sensing lead
and an attempt was made to unscrew the lead, which was
unsuccessful. A locking stylet was inserted into the sensing
lead and using gentle traction, the lead was extracted without
any difﬁculty. The platysma muscle was reapproximated in
the neck and both the right cervical and pocket wounds were
closed with absorbable suture.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.11.007
KEY TEACHING POINTS
 The CardioFit vagal nerve stimulator is an emerging
implantable device in heart failure patients.
 Extraction of this device is performed best with
operators who have an in-depth knowledge of vital
structures in the cervical area.
 As lead extractions become more complex, a
multidisciplinary approach involving cardiac
surgeons will be paramount.
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infected device was removed in a similar fashion to the CardioFit
device. The 2 leads of the AICD system were aMedtronic 6947-
58 cm Sprint Quattro Secure active-ﬁxation AICD lead in the
right ventricular apex and a Medtronic CapSureFix Novus 4076-
45 cm active-ﬁxation lead placed in the right atrial appendage.
These leads were easily extracted with the assistance of the
Spectranetics Excimer CVX-300 Laser System (Colorado
Springs, CO). Excisional debridement of the device capsule
and infected skin edges were performed to the infected pocket
and skin. A wound V.A.C. was placed on the ICD pocket
wound. The patient left the operating room in stable condition
and was discharged several days later following wound vac
removal and delayed primary closure of his wound was
performed 8 days later without incident. The patient was sent
home with a LifeVest (Zoll Medical Corporation, Pittsburgh,
PA) until reimplantation of a new AICD. The patient was given
intravenous antibiotics appropriate for methicillin-sensitive
Staphylococcus aureus for 10 days, then the patient was kept
on oral antibiotics for an additional week. AICD reimplantation
was subsequently scheduled with the patient’s primary
electrophysiologist.Figure 1 A: Posteroanterior chest radiograph image of dual-chamber
automatic implantable cardioverter-deﬁbrillator (AICD) (device on the left
side) and vagal nerve stimulator on the right side. Note the cuff of the vagal
nerve stimulator positioned on the right cervical area. B: Infection and
erosion of the AICD pocket with purulent discharge.Discussion
The incidence of intracardiac device infections has seen steady
growth over the past 2 decades. This is in part because of the
growing number of pacemakers, deﬁbrillators, and resynchro-
nization devices. Extraction of these devices has traditionally
been very complex and associated with a high mortality. With
the emergence of new technology such as laser and mechanical
rotational sheaths, lead extraction has become much more
feasible2-5. Devices such as the CardioFit, which has leads that
are extracardiac, require additional skill and expertise. If
careful dissection of the lead is not done, it can lead to damage
of vital structures, including the carotid artery, the internal
jugular vein, and the vagus nerve. As the heart failure patient
population continues to grow, the use of devices for auto-
nomic regulation and pressure sensing will also increase.
These devices may have extracardiac as well as intracardiac
components, making extraction a more in-depth and complex
procedure.5 The design of new implantable intracardiac
devices needs to take into consideration the possibility of
device infections and that extraction will be required.Therefore, ease of extraction is an important factor that needs
to be incorporated in future device design. Operators that are
explanting devices need to expand their surgical skills or adopt
multidisciplinary teams to tackle such complex extractions.We
present the ﬁrst ever case of the CardioFit neurotransmitter
device owing to infection. By incorporating a multidisciplinary
effort involving cardiothoracic surgeons and cardiac electro-
physiologists, we were able to safely and effectively remove all
implanted devices without any morbidity to the patient.Conclusion
Laser lead extraction procedures will increase in technical
complexity as the heart failure population grows and there is
a higher utilization of implantable intracardiac devices for
Figure 2 A: Surgical picture of vagal nerve stimulator cuff on the vagus nerve.B:Once the cuff was removed, the vagus nerve was left without any signiﬁcant
damage. C: Both the pulse generator and the nerve stimulator cuff. D: Inspection of the vagal nerve cuff showed no signiﬁcant adhesions or damage.
Heart Rhythm Case Reports, Vol 2, No 3, May 2016210pressure monitoring and autonomic regulation. Therefore, a
multidisciplinary approach with electrophysiology and car-
diac surgery is required for such complex cases.
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